SCHEMBL6172371

SCHEMBL6172371

Cc1cccc2nccc(C(C)C3NC(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C3=O)c12

nearest known ligand 0.45

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.45
LMNA P02545 2/20 0.34
TRPV3 Q8NET8 2/20 0.32
PARP1 P09874 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173570 0.91 IGF1R (0.43) IGF1RLMNATRPV3
SCHEMBL6172919 0.91 IGF1R (0.43) IGF1RLMNATRPV3
SCHEMBL6169084 0.90 IGF1R (0.44) IGF1RLMNATRPV3
SCHEMBL6175238 0.85 IGF1R (0.43) IGF1RLMNATRPV3PARP1MAPK1
SCHEMBL6174189 0.83 IGF1R (0.42) IGF1RLMNATRPV3HTT
SCHEMBL6175175 0.81 IGF1R (0.36) IGF1RLMNAMAPK1HTTSMN1; SMN2
SCHEMBL6173471 0.80 IGF1R (0.42) IGF1RLMNA
SCHEMBL6250336 0.80 IGF1R (0.43) IGF1RLMNA
SCHEMBL6173625 0.79 IGF1R (0.44) IGF1RTRPV3PARP1SMN1; SMN2
SCHEMBL6173787 0.79 IGF1R (0.42) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed